304 related articles for article (PubMed ID: 23373475)
1. The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: a population based study in Modena, Italy.
Georgoulopoulou E; Fini N; Vinceti M; Monelli M; Vacondio P; Bianconi G; Sola P; Nichelli P; Mandrioli J
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):338-45. PubMed ID: 23373475
[TBL] [Abstract][Full Text] [Related]
2. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
[TBL] [Abstract][Full Text] [Related]
3. Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.
Mandrioli J; Malerba SA; Beghi E; Fini N; Fasano A; Zucchi E; De Pasqua S; Guidi C; Terlizzi E; Sette E; Ravasio A; Casmiro M; Salvi F; Liguori R; Zinno L; Handouk Y; Rizzi R; Borghi A; Rinaldi R; Medici D; Santangelo M; Granieri E; Mussuto V; Aiello M; Ferro S; Vinceti M;
J Neurol; 2018 Apr; 265(4):817-827. PubMed ID: 29404735
[TBL] [Abstract][Full Text] [Related]
4. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.
Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M
BMJ Open; 2016 Sep; 6(9):e012054. PubMed ID: 27694488
[TBL] [Abstract][Full Text] [Related]
5. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive and invasive ventilation and enteral nutrition for ALS in Italy.
Fini N; Georgoulopoulou E; Vinceti M; Monelli M; Pinelli G; Vacondio P; Giovannini M; Dallari R; Marudi A; Mandrioli J
Muscle Nerve; 2014 Oct; 50(4):508-16. PubMed ID: 24448736
[TBL] [Abstract][Full Text] [Related]
7. Tracheostomy mechanical ventilation in patients with amyotrophic lateral sclerosis: clinical features and survival analysis.
Spataro R; Bono V; Marchese S; La Bella V
J Neurol Sci; 2012 Dec; 323(1-2):66-70. PubMed ID: 22989611
[TBL] [Abstract][Full Text] [Related]
8. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort.
Berlowitz DJ; Howard ME; Fiore JF; Vander Hoorn S; O'Donoghue FJ; Westlake J; Smith A; Beer F; Mathers S; Talman P
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):280-6. PubMed ID: 25857659
[TBL] [Abstract][Full Text] [Related]
9. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Moore DH
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD001447. PubMed ID: 22419278
[TBL] [Abstract][Full Text] [Related]
10. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in amyotrophic lateral sclerosis: a population-based study.
Pupillo E; Messina P; Logroscino G; Beghi E;
Ann Neurol; 2014 Feb; 75(2):287-97. PubMed ID: 24382602
[TBL] [Abstract][Full Text] [Related]
12. Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole.
Sívori M; Rodríguez GE; Pascansky D; Sáenz C; Sica RE
Medicina (B Aires); 2007; 67(4):326-30. PubMed ID: 17891927
[TBL] [Abstract][Full Text] [Related]
13. Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy.
Chiò A; Calvo A; Ghiglione P; Mazzini L; Mutani R; Mora G;
J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1141-3. PubMed ID: 20660920
[TBL] [Abstract][Full Text] [Related]
14. Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
Turner MR; Bakker M; Sham P; Shaw CE; Leigh PN; Al-Chalabi A
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):15-21. PubMed ID: 12061944
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting survival in ALS: a multicenter Italian study.
Calvo A; Moglia C; Lunetta C; Marinou K; Ticozzi N; Ferrante GD; Scialo C; Sorarù G; Trojsi F; Conte A; Falzone YM; Tortelli R; Russo M; Chiò A; Sansone VA; Mora G; Silani V; Volanti P; Caponnetto C; Querin G; Monsurrò MR; Sabatelli M; Riva N; Logroscino G; Messina S; Fini N; Mandrioli J
J Neurol; 2017 Jan; 264(1):54-63. PubMed ID: 27778156
[TBL] [Abstract][Full Text] [Related]
16. Improvements in the multidisciplinary care are beneficial for survival in amyotrophic lateral sclerosis (ALS): experience from a tertiary ALS center.
Klavžar P; Koritnik B; Leonardis L; Dolenc Grošelj L; Kirbiš M; Ristić Kovačič S; Klinar P; Pohar Perme M; Zidar J
Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):203-208. PubMed ID: 32248716
[No Abstract] [Full Text] [Related]
17. Survival of patients with amyotrophic lateral sclerosis in a population-based registry.
Millul A; Beghi E; Logroscino G; Micheli A; Vitelli E; Zardi A
Neuroepidemiology; 2005; 25(3):114-9. PubMed ID: 15956808
[TBL] [Abstract][Full Text] [Related]
18. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
[TBL] [Abstract][Full Text] [Related]
19. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Moore DH
Cochrane Database Syst Rev; 2000; (2):CD001447. PubMed ID: 10796796
[TBL] [Abstract][Full Text] [Related]
20. A clinical tool for predicting survival in ALS.
Knibb JA; Keren N; Kulka A; Leigh PN; Martin S; Shaw CE; Tsuda M; Al-Chalabi A
J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1361-1367. PubMed ID: 27378085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
